Sermorelin

Sermorelin was once FDA-approved under the brand Geref®, but the commercial product was discontinued for business reasons and not for safety concerns.

Today, Sermorelin is available only as a compounded medication supporting personalized peptide-based wellness strategies and is prepared for individual patients under clinician oversight.

Clients choose Sermorelin when their provider recommends a customized peptide option within a structured monitoring plan.